Table 6. Results From MV Analysis in Normal and Low Albumin Groups.

Outcome	Normal vs. low albumin group (primary group)			Medium low vs. very low albumin group (subgroup)
	Odds ratio	95% CI	P-value	Odds ratio	95% CI	P-value
Albumin level (lower ref to higher)	10.88	4.74 - 24.97	< 0.001*	7.94	1.70 - 37.14	0.009*
Age	1.00	0.98 - 1.02	0.56	0.99	0.91 - 1.02	0.81
Sex	0.77	0.41 - 1.47	0.44	1.5	0.71 - 3.18	0.27
Race
White	0.37	0.16 - 0.82	0.015*	1.77	0.59 - 5.32	0.30
Others	0.73	0.33 - 1.63	0.45	1.16	0.49 - 2.71	0.72
Smoking	1.93	0.81 - 4.5	0.13	0.52	0.20 - 1.33	0.17
DM	0.61	0.32 - 1.19	0.15	1.12	0.52 - 2.40	0.76
HTN	1.04	0.46 - 2.36	0.91	0.38	0.14 - 1.04	0.06
CKD	0.54	0.22 - 1.32	0.18	2.04	0.66 - 6.32	0.21
ESRD on HD	1.11	0.30 - 4.11	0.86	0.38	0.08 - 1.69	0.20
COPD	0.41	0.13 - 1.21	0.1	1.30	0.34 - 4.92	0.69
CHF	1.40	0.45 - 4.32	0.55	4.78	1.06 - 21.38	0.041*
CAD	0.67	0.26 - 1.72	0.40	0.75	0.26 - 2.16	0.60
HIV	1.46	0.14 - 14.93	0.74	1
Malignancy	11.34	2.05 - 62.64	0.005*	0.78	0.20 - 2.99	0.72
Alcohol dependency	1.58	0.40 - 6.19	0.50	3.35	0.62 - 17.86	0.15
Obesity	0.66	0.35 - 2.14	0.22	0.66	0.31 - 1.39	0.28
Other lung disease	0.87	0.35 - 2.14	0.77	0.31	0.12 - 0.78	0.014*
Cirrhosis	0.06	0.08 - 0.57	0.014*	1.45	0.09 - 22.22	0.78

MV controlled for age; sex; race; diabetes mellitus (DM); hypertension (HTN); chronic kidney disease (CKD); end-stage renal disease (ESRD) on hemodialysis (HD); chronic obstructive pulmonary disease (COPD); other lung diseases; congestive heart failure (CHF); coronary artery disease (CAD); human immunodeficiency virus (HIV) infection; malignancy; smoking; alcohol dependency; obesity; and cirrhosis. *Significant P-values. MV: multivariate; CI: confidence interval.